Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Genetics of Early- and Late-Onset Alzheimer’s Disease
Md. Sahab Uddin, Sharifa Hasana, Md. Farhad Hossain, et al.
Current Gene Therapy (2020) Vol. 21, Iss. 1, pp. 43-52
Closed Access | Times Cited: 22

Showing 22 citing articles:

From Menopause to Neurodegeneration—Molecular Basis and Potential Therapy
Yu‐Jung Cheng, Chieh‐Hsin Lin, Hsien‐Yuan Lane
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8654-8654
Open Access | Times Cited: 56
The Potential Benefits of Nanotechnology in Treating Alzheimer’s Disease
Tan Sook Ling, Shanthini Chandrasegaran, Zhi Xuan Low, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 43
Regulation of the Late Onset alzheimer’s Disease Associated HLA-DQA1/DRB1 Expression
Xiaoyu Zhang, Meijaun Zou, Yuwei Wu, et al.
American Journal of Alzheimer s Disease & Other Dementias® (2022) Vol. 37
Open Access | Times Cited: 30
The role of glycogen synthase kinase 3 beta in neurodegenerative diseases
Honglu Yu, Min Xiong, Zhentao Zhang
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 20
Role of MicroRNA-502-3p in Human Diseases
Davin Devara, Yashmit Choudhary, Subodh Kumar
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 532-532
Open Access | Times Cited: 16
Early- and Late-Onset Alzheimer’s Disease: Two Sides of the Same Coin?
César A. Valdez-Gaxiola, Frida Rosales-Leycegui, Abigail Gaxiola-Rubio, et al.
Diseases (2024) Vol. 12, Iss. 6, pp. 110-110
Open Access | Times Cited: 5
ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer’s disease
Christopher E. Ramsden, Daisy Zamora, Mark S. Horowitz, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Non-coding RNAs involved in the molecular pathology of Alzheimer’s disease: a systematic review
Reynand Jay Canoy, J Sy, Christian Deo T. Deguit, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Neuron-Astrocyte Interactions in Aging and Alzheimer's Disease: Dysregulation of Amyloid Precursor Protein
Gretsen Velezmoro Jáuregui, Vladimir Parpura
Ageing & Longevity (2025), Iss. 2. 2025, pp. 117-128
Closed Access
Experimental colitis in young Tg2576 mice accelerates the onset of an Alzheimer’s-like clinical phenotype
Luca Lorenzini, Lorenzo Zanella, Michele Sannia, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Clinical and Molecular Findings in a Turkish Family Who Had a (c.869- 1G>A) Splicing Variant in PSEN1 Gene with A Rare Condition: The Variant Alzheimer's Disease with Spastic Paraparesis
Mustafa Doğan, Recep Eröz, Mehmet Tecellioğlu, et al.
Current Alzheimer Research (2022) Vol. 19, Iss. 3, pp. 223-235
Closed Access | Times Cited: 6
Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease
Undine Haferkamp, Carla Hartmann, Chaudhry Luqman Abid, et al.
Fluids and Barriers of the CNS (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Altered Blood and Brain Expression of Inflammation and Redox Genes in Alzheimer’s Disease, Common to APPV717I × TAUP301L Mice and Patients
Cătălina Anca Cucoș, Elena Milanesi, Maria Dobre, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5799-5799
Open Access | Times Cited: 5
PSEN2 and ABCA7 variants causing early-onset preclinical pathological changes in Alzheimer's disease: a case report and literature review
Jiale Gan, Hui Zhou, Chao Liu, et al.
Neurological Sciences (2023) Vol. 44, Iss. 6, pp. 1987-2001
Closed Access | Times Cited: 2
Recent Progress in the Treatment Strategies for Alzheimer’s Disease
Vinay Kumar, Kunal Roy
Neuromethods (2023), pp. 3-47
Closed Access | Times Cited: 2
Diet-induced metabolic and immune impairments are sex-specifically modulated by soluble TNF signaling in the 5xFAD mouse model of Alzheimer’s disease
Maria Elizabeth de Sousa Rodrigues, MacKenzie L. Bolen, Lisa Blackmer‐Raynolds, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Impact of Long-Term Dietary High Fat and Eicosapentaenoic Acid on Behavior and Hypothalamic-Pituitary-Adrenal Axis Activity in Amyloidogenic APPswe/PSEN1dE9 Mice
Breanna N. Harris, Mahsa Yavari, Latha Ramalingam, et al.
Neuroendocrinology (2024) Vol. 114, Iss. 6, pp. 553-576
Closed Access
Understanding the Intricate Role of Exosomes in Pathogenesis of Alzheimer’s Disease
Simran Chauhan, Tapan Behl, Aayush Sehgal, et al.
Neurotoxicity Research (2022) Vol. 40, Iss. 6, pp. 1758-1773
Closed Access | Times Cited: 2
Gene Therapy for Neuroprotection and Neurorestoration (Part II)
Ghulam Md Ashraf, Md. Sahab Uddin
Current Gene Therapy (2020) Vol. 20, Iss. 3, pp. 163-163
Closed Access | Times Cited: 2
Gene Therapy for Neuroprotection and Neurorestoration-Part III
Ghulam Md Ashraf, Md. Sahab Uddin
Current Gene Therapy (2021) Vol. 21, Iss. 1, pp. 2-2
Closed Access | Times Cited: 1
Mitochondria in human reproduction: novel paradigm in the onset of neurodegenerative disorders
Miki Shavit, María Iniesta‐Cuerda, Jan Nevoral
Physiological Research (2023), Iss. Vol 72(2), pp. 137-148
Open Access
Common pathogenetic factors in metabolic syndrome and dementia
Vesna Lukinović-Škudar, Vesna Đermanović Dobrota
Rad Hrvatske akademije znanosti i umjetnosti Medicinske znanosti (2022) Vol. 60-61, pp. 74-83
Open Access
Page 1

Scroll to top